↓ Skip to main content

Dove Medical Press

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

Overview of attention for article published in Journal of Hepatocellular Carcinoma, September 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
googleplus
1 Google+ user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
25 Mendeley
Title
Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
Published in
Journal of Hepatocellular Carcinoma, September 2015
DOI 10.2147/jhc.s44380
Pubmed ID
Authors

Ji Hye Jang, Jin-Woo Lee, Ji Taek Hong, Young-Joo Jin

Abstract

Transarterial chemoembolization (TACE) is the standard treatment for patients with Barcelona Clinic Liver Cancer-intermediate stage hepatocellular carcinoma (HCC). The concept of drug-eluting bead TACE builds on the rationale of intratumoral drug delivery, and drug-eluting bead TACE has been shown to provide consistent and reliable results and to significantly diminish systemic drug exposure, liver toxicity, and drug-related adverse events as compared with conventional TACE. Based on the belief that combinations of TACE and other local or systemic therapies have several theoretical advantages, many clinical trials have been conducted to evaluate the effectiveness of TACE in combination with local treatment such as radiofrequency ablation or radiotherapy, and systemic therapy such as sorafenib or another molecular therapy. TACE has also been used as a preoperative adjuvant chemotherapy in patients with HCC to improve survival and as a bridging therapy before liver transplantation to downstage HCC. In the present evidence-based review, the authors summarize the current status of these transcatheter arterial embolic therapies in HCC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 16%
Student > Master 4 16%
Researcher 3 12%
Lecturer 2 8%
Student > Ph. D. Student 2 8%
Other 5 20%
Unknown 5 20%
Readers by discipline Count As %
Medicine and Dentistry 14 56%
Engineering 2 8%
Chemistry 1 4%
Immunology and Microbiology 1 4%
Unknown 7 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2015.
All research outputs
#15,168,964
of 25,373,627 outputs
Outputs from Journal of Hepatocellular Carcinoma
#61
of 262 outputs
Outputs of similar age
#135,203
of 276,788 outputs
Outputs of similar age from Journal of Hepatocellular Carcinoma
#1
of 4 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 262 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,788 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them